Phone: 959-333-0983
Phone: 959-333-0983
$56.99
This item has been third-party tested by accredited U.S. laboratories and confirmed to meet a minimum purity of 98% through rigorous verification standards.
$56.99
Non-steroidal Selective Androgen Receptor Modulator (SARM) — liquid solution. Supplied by Research Chemical exclusively for laboratory research use.
25 mg/mL concentration, UV-resistant glass.
Independently analyzed by an accredited third-party lab.
Pharmaceutical-grade carrier, bottled in the USA.
Supplied exclusively for laboratory investigation.
| Compound Class | Non-steroidal Selective Androgen Receptor Modulator (SARM) |
|---|---|
| Form | Liquid solution in USP-grade PEG-400 |
| Concentration | 25 mg/mL |
| Volume | 30 mL per bottle |
| CAS Number | 841205-47-8 |
| Chemical Formula | C19H14F3N3O3 |
| Molar Mass | 389.32 g/mol |
| Synonyms | MK-2866, Ostarine, Enobosarm, GTx-024 |
| Verified Purity | Batch-tested to 98% (HPLC) |
For laboratory research use only. Not for human or animal consumption.
Each compound in this listing is analyzed by an accredited third-party laboratory before it ships.
Most recent batch certificate of analysis, issued by MZ Biolabs (Tucson, AZ). Click to view full size on the certificates page.
Every batch sold by Research Chemical is independently analyzed before it ships.
This product is an investigational compound and is not a drug, food, dietary supplement, or cosmetic. It is not approved for human or animal use, and it is unlawful to market it for that purpose.
MK-2866 (Ostarine) is a SARM and is prohibited by the World Anti-Doping Agency (WADA) at all times under S1 (Anabolic Agents).
Research Chemical makes no representations regarding the safety or effects of this compound in humans or animals.
Research Chemical is a chemical supplier, not a medical provider. We do not condone or encourage consumer use of research compounds.
Research use only. All products sold by Research Chemical are intended exclusively for laboratory research and development. They are not for human or animal consumption. These statements have not been evaluated by the U.S. Food and Drug Administration, and these products are not intended to diagnose, treat, cure, or prevent any disease.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Research Chemical products are third-party tested by MZ Biolabs, an independent laboratory based in Arizona. Each batch is analyzed to ensure accuracy, purity, and that all specifications are met.
By purchasing from ResearchChemical.com, you acknowledge that you are acquiring research chemicals intended solely for scientific investigation.
MK-2866 is:
The information provided on this website is for educational and informational purposes only and should not be interpreted as medical advice. ResearchChemical.com assumes no liability for misuse, improper handling, or use outside of controlled research environments. It is the purchaser’s responsibility to ensure compliance with all applicable laws and regulations.
2. Komrakova, M., Furtwängler, J., Hoffmann, D.B. et al. The Selective AR Modulator Ostarine Improves Bone Healing in Ovariectomized Rats. GW 501516 Calcif Tissue Int 106, 147–157 (2020)
3. Yuan Y, Lee JS, Yost SE, Frankel PH, Ruel C, Egelston CA, Guo W, Gillece JD, Folkerts M, Reining L, Highlander SK, Robinson K, Padam S, Martinez N, Tang A, Schmolze D, Waisman J, Sedrak M, Lee PP, Mortimer J. A Phase II Clinical Trial of Pembrolizumab and Enobosarm in Patients with Androgen Receptor-Positive Metastatic Triple-Negative Breast Cancer. Oncologist. 2021 Feb;26(2):99-e217. doi: 10.1002/onco.13583. Epub 2020 Nov 24. PMID: 33141975; PMCID: PMC7873338.
4. Leciejewska N, Pruszynska-Oszmalek E, Bien J, Nogowski L, Kolodziejski PA. Effect of ostarine (enobosarm/GTX024), a selective androgen receptor modulator, on adipocyte metabolism in Wistar rats. J Physiol Pharmacol. 2019 Aug;70(4). doi: 10.26402/jpp.2019.4.04. Epub 2019 Oct 19. PMID: 31642815.
5. Hoffmann DB, Komrakova M, Pflug S, von Oertzen M, Saul D, Weiser L, Walde TA, Wassmann M, Schilling AF, Lehmann W, Sehmisch S. Evaluation of ostarine as a selective androgen receptor modulator in a rat model of postmenopausal osteoporosis. J Bone Miner Metab. 2019 Mar;37(2):243-255. doi: 10.1007/s00774-018-0929-9. Epub 2018 May 21. PMID: 29785666.
6. Dalton JT, Barnette KG, Bohl CE, Hancock ML, Rodriguez D, Dodson ST, et al. The selective androgen receptor modulator GTx‐024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double‐blind, placebo‐controlled phase II trial. MK 677. J Cachexia Sarcopenia Muscle, 2011;2:153–161
Join our insider list for the latest research insights, product releases, and special offers—delivered straight to your inbox.